A
RNA
Atrium Therapeutics, Inc
13.44
-0.03-0.22%After Hours: 13.44 0.00 0.00%16:33 04/02 EDT
OPEN/PREV CLOSE13.40/13.47
TODAY RANGE13.31-13.71
VOL281.73K
MARKET CAP230.02M
52 WEEK RANGE11.95-16.77
AVG VOL (3M)1.24M
% TURNOVER1.65%
TURNOVER--
P/E (TTM)-4.6467
% RANGE2.97%
EPS(TTM)-2.8924
P/E(FORWARD)-3.2464
P/B-3.6678
BVPS-3.6643
DIVIDEND--
P/S12.35
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP208.52M
SHARES OUTSTANDING17.11M
NEXT EARNINGS05/06-05/11
FREE FLOAT15.51M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/16 03:25
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
Dow Jones·03/11 13:37
Avidity Biosciences Price Target Announced at $25.00/Share by Wells Fargo
Dow Jones·03/11 13:37
Avidity Biosciences Initiated at Overweight by Wells Fargo
TipRanks·03/11 12:46
Largest borrow rate increases among liquid names
TipRanks·03/10 20:27
Atrium Therapeutics initiated with an Overweight at Wells Fargo
TipRanks·03/08 20:55
Controversial Prasad leaving FDA, NYT reports
Seeking Alpha·03/05 15:05
Most and least shorted small-to-mid-cap stocks
TipRanks·02/27 17:15
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories!
TipRanks·02/27 15:15
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
TipRanks·02/27 14:25
Atrium Therapeutics launches as newly independent, publicly traded company
TipRanks·02/27 14:07
Why Is Avidity Biosciences Stock (RNA) Down Today?
Benzinga·02/27 09:43
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.